Back to discover
Drug

bisphenol A

Research stage
Emerging researchRising momentum
RxNorm1433347ChEMBLCHEMBL418971UNIIMLT3645I99
5
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Concentrations of bisphenol A and selected bisphenol analogues in urban reservoirs in different seasonal conditions

Industry2026-07-29Nature — Environmental Sciences

Integrated metabolomic and histopathological analysis of renal alterations in mice following chronic bisphenol A (BPA) exposure

Industry2026-07-16Nature — Environmental Sciences

Environmental bisphenol A exposure triggers trained immunity-related pathways in monocytes.

Research2023-11-23Frontiers in immunology

Bisphenol A alters retinal morphology, visually guided behavior, and thyroid hormone levels in zebrafish larvae.

Research2023-11-22Chemosphere

Effect of bisphenol A on the neurological system: a review update.

Research2023-10-19Archives of toxicology

Potential Mechanisms of Bisphenol A (BPA) Contributing to Human Disease.

Research2020-08-11International journal of molecular sciences

Bisphenol S and F: A Systematic Review and Comparison of the Hormonal Activity of Bisphenol A Substitutes.

Research2015-03-16Environmental health perspectives

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
bisphenol A
RxNorm CUI
1433347
ChEMBL ID
CHEMBL418971
UNII
MLT3645I99

Research activity

5 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20152024
Major research themes7
Autism Spectrum Disorder1Disease1Endocrine Disruptors1Monocytes1Thyroid Hormones1Tumor Necrosis Factor-alpha1Zebrafish1
Journals, researchers & institutions
Top journals
  • Archives of toxicology1
  • Chemosphere1
  • Environmental health perspectives1
  • Frontiers in immunology1
  • International journal of molecular sciences1
Leading researchers
  • Beguinot F1
  • Bolden AL1
  • Cairrao E1
  • Cimmino I1
  • Cipullo M1
  • Coppola A1
  • Costa HE1
  • Dallio M1
Leading institutions
free-text, unnormalised
  • Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI)1
  • Federico II University of Naples and URT "Genomic of Diabetes" of Institute of Experimental Endocrinology and Oncology1
  • Health Sciences Research Centre1
  • Life and Medical Sciences Institute (LIMES)1
  • University of Aarhus1
  • University of Beira Interior1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature